论文部分内容阅读
81例经胃镜证实的HP阳性十二指肠溃疡患者，随机分成二组分别接受兰索拉唑三联或二联疗法根除HP治疗。服法：三联组兰索拉唑30mg，每日2次，阿莫西林0．5g及甲硝唑0．4g，每日3次；二联组兰索拉唑服法同上，阿莫西林0．5g,每日4次。疗程均为10d.结果：三联组根除率为95％（38／40），高于二联组80．5％（33／41）（P＜0.05）；溃疡愈合率分别为87．5％及87．8％；副反应发生率分别为15％（6／40）及4．9％（2／41），P＞0．05。结果表明：兰索拉唑三联疗法具有症状缓解迅速、HP根除率高、副反应轻、依从性好等优点，是一种较理想的根除HP治疗方案。
Eighty-one patients with HP-positive duodenal ulcer confirmed by gastroscope were randomly divided into two groups to receive Lansoprazole triple or dual therapy respectively to eradicate HP. Service method: triple group of Lansoprazole 30mg, 2 times a day, amoxicillin 0.5g and metronidazole 0.4g, 3 times a day; the second group of lansoprazole treatment method Ibid, amoxicillin 0 .5g, 4 times a day. The results showed that the cure rate was 95% (38/40) in the triple group, 80.5% (33/41) in the combined group (P <0.05), and the healing rates of the ulcer were 87.5% and 87.8%; the incidence of side effects were 15% (6/40) and 4.9% (2/41) respectively, P> 0.05. The results showed that: Lansoprazole triple therapy with rapid relief of symptoms, HP eradication rate, mild side effects, and good compliance, is an ideal eradication of HP treatment options.